Toregem is aiming to commercialize a groundbreaking antibody drug for tooth regeneration. Learn more about the Kyoto-based organization in this installment of our Let’s Interview Series.
Venture Valuation (VV) interviewed Dr. KISO Honoka, D.D.S., Ph.D., Co-founder and CEO.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?